Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs75537694 | chr2:118531587 | G/A | 1.79E-5 | 177 | 25.17 | 25.75 | 11.65 | KM Plot |
PCPG | rs75566647 | chr21:38445968 | C/T | 1.19E-8 | 174 | 25 | 25.87 | 3.83 | KM Plot |
PCPG | rs75570346 | chr16:90048080 | G/C | 1.11E-8 | 172 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs75589685 | chr2:121543257 | G/T | 0.000214 | 177 | 25.53 | 24.37 | 59.77 | KM Plot |
PCPG | rs7559497 | chr2:118518819 | A/G | 1.48E-5 | 178 | 24.85 | 28.8 | 11.65 | KM Plot |
PCPG | rs75598973 | chr12:56746558 | C/T | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
PCPG | rs7561484 | chr2:107207725 | A/G | 0.000219 | 177 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs75616938 | chr17:1424837 | G/A | 1.25E-5 | 177 | 24.7 | 26.73 | 13.02 | KM Plot |
PCPG | rs75620045 | chr2:118704883 | T/A | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs7564507 | chr2:61495193 | G/A | 8.37E-5 | 174 | 23.43 | 31.48 | 10.3 | KM Plot |
PCPG | rs75654641 | chr5:179486021 | C/T | 1.41E-5 | 175 | 24.37 | 32.15 | 25.17 | KM Plot |
PCPG | rs75659293 | chr17:1461195 | G/C | 1.47E-5 | 175 | 24.53 | 25.87 | 25.17 | KM Plot |
PCPG | rs7566358 | chr2:107254241 | A/G | 0.000336 | 172 | 26.57 | 21.95 | 25.87 | KM Plot |
PCPG | rs7567487 | chr2:24319352 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs7567612 | chr2:118530096 | C/G | 0 | 178 | 24.85 | 30.93 | 3.17 | KM Plot |